Pulmonary hypertension: diagnosis and management.
Authors:
- Michael D McGoonMMMichael D McGoon
- Garvan C KaneGKGarvan C Kane
- 1 February 2009
- journal article
- Published by Dougmar Publishing Group, Inc.
- Vol. 84 (2) , 191-207
Abstract
Pulmonary arterial hypertension is a progressive, symptomatic, and ultimately fatal disorder for which substantial advances in treatment have been made during the past decade. Effective management requires timely recognition and accurate diagnosis of the disorder and appropriate selection among therapeutic alternatives. Despite progress in treatment, obstacles remain that impede the achievement of optimal outcomes. The current article provides an overview of the pathobiologic mechanisms of pulmonary arterial hypertension, including genetic substrates and molecular and cellular mechanisms, and describes the clinical manifestations and classification of pulmonary arterial hypertension. The article also reviews established approaches to evaluation and treatment, with emphasis on the appropriate application of calcium channel blockers, prostacyclin analogues, endothelin receptor antagonists, and phosphodiesterase 5 inhibitors. In addition, the authors discuss unresolved issues that may complicate patient management, such as the clinical importance of mild or exercise-related pulmonary arterial hypertension, and they identify avenues by which treatment may advance in the future through the use of combination treatment, outcomes assessment, and exploration of alternative pharmacologic strategies.Keywords
This publication has 98 references indexed in Scilit:
- Pathobiology of Pulmonary HypertensionAnnual Review of Pathology: Mechanisms of Disease, 2007
- Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary HypertensionCirculation, 2006
- Efficacy and Safety of Sildenafil Added to Treprostinil in Pulmonary HypertensionThe American Journal of Cardiology, 2005
- Decreased Whole Body Endogenous Nitric Oxide Production in Patients with Primary Pulmonary HypertensionJournal of Vascular Research, 2005
- Clinical classification of pulmonary hypertensionJACC, 2004
- Serotonin-Induced Smooth Muscle Hyperplasia in Various Forms of Human Pulmonary HypertensionCirculation Research, 2004
- Appetite-Suppressant Drugs and the Risk of Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndromeThe American Journal of Cardiology, 1993
- Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertensionThe American Journal of Cardiology, 1985
- Primary pulmonary hypertension: natural history and the importance of thrombosis.Circulation, 1984